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Abstract
Background: Health-related Quality of life (HRQoL) is a major goal of clinical management after liver transplantation
(LTx). There is still disagreement on the effects of social-demographic factors and changes in the allocation system on
HRQoL. The aim of this study was to evaluate the impact of social-demographic factors, mode of organ-allocation,
waiting time and hepatocellular carcinoma (HCC) on HRQoL after LTx.
Methods: HRQoL was assessed using the EORTC-QLQ-C30 questionnaire, which was sent to 238 recipients.
Investigated parameters included age, sex, distance to transplant center, follow-up at hospital, size of
hometown, highest education, marital status, having children, background liver disease, waiting time, mode of
allocation, HCC, hospitalization after LTx and diagnosis of malignancy after LTx. All evaluated parameters were
entered into multivariate linear regression analysis.
Results: Completed questionnaire were returned by 73 % of the recipients. After LTx, the HRQoL-function
scales increased over time. Age, marital status, highest education, completed professional training, working
status, job position, duration of waiting time to LTx, distance to transplant center, place offollow, HU-statuts,
mode of organ allocation and duration of hospitalization were associated with significantly worse function-
and significantly lower symptom scales. HCC as a primary disease did not affect HRQoL.
Conclusions: Low HRQoL correlated significantly with MELD-based organ allocation, more than 28-day
hospitalization, divorced status, lower education- and non-working status, higher distance to transplant center,
follow up at transplant center, HU-status, shorter waiting time to LTx and younger age. Improvement of
HRQoL after LTx may require clinical management of pain, psychotherapy and financial support.
Keywords: Liver transplantation, Quality of life, Allocation-system, Social demographic factors, Age, Sex, HCC,
Waiting time
Introduction
Since the reporting of the first liver transplantation (LTx)
in 1963 by Starzl et al. [1], the estimated overall 1-year and
5-year survival rates exceed 85 and 70 % [2] and LTx has
become the standard therapy for end-stage liver disease. In
the past years, health-related quality of life (HRQoL) after
LTx has gained more interest in the transplantation
community. HRQoL is assessed by a questionnaire that
encompasses physical ability, psyche, socio-economic fac-
tors and interpersonal level measured over certain period
of time. Several studies reported homogeneous results
concerning HRQoL after LTx and showed a significant im-
provement of physical efficiency one year after LTx [3–5].
Such improvement covered fatigue, weakness and coping
with problems of everyday life activities [6–8]. Especially,
recurrence of liver disease [8–11] and ability to work were
identified as main factors to influence HRQoL after LTx.
However, there is still disagreement on whether HRQoL is
influenced by various social demographic factors.
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The aim of this study was to identify social demo-
graphic factors that influence HRQoL after LTx. We fo-
cused on the effects of age at the time of LTx, job
position as well as education- and working-status, since
LTx is being conducted increasingly in older patients
over the years and financial difficulty has been identified
to be a major problem after LTx. We also evaluated the
effects of marital status and social networking, since LTx
patients might benefit from the help of family members
or friends after transplantation. We also evaluated the
effects of the new mode of organ allocation. Specifically,
the European Liver Allocation System (ELAS) was re-
placed in 2006 by the Model for End-Stage Liver Disease
(MELD) to reduce mortality on the waiting list and to
optimize organ allocation for LTx. Based on this change,
hepatocellular carcinoma (HCC) became the second
most common indication for LTx and patients with
HCC could undergo LTx through a faster allocation
using the implemented match-MELD, where patients
with stable HCC disease inside the Milan Criteria (MC)
are transplanted by primary donor organs. The stable
tumor disease within MC needs to be verified every
3 months and leads to additional match-MELD-points
corresponding to +10 % of the 3-month mortality. Based
on the increased proportion of patients with HCC on
the LTx waiting list, we analyzed the impact of HCC,
compared to non-tumor liver disease, on HRQoL. In
addition, we analyzed the impact of the waiting time to
LTx on the HRQoL.
Material and methods
Study cohort
Between 1988 and 2013, 660 adult patients underwent
LTx at the UKSH, Campus Kiel. Of these 660, 252 pa-
tients fulfilled the criteria used for study entry and were
enrolled in the study. The inclusion criteria were 1) pa-
tients who had undergone a deceased donor organ LTx,
and 2) patients who underwent re-transplantation for
organ failure. The exclusion criteria were 1) Patients
younger than 16 years, 2) patients who had died during
follow-up, 3) patients with a combination organ trans-
plantation, 4) living donor liver transplant recipients,
and 5) non-residents. Patients were followed up for a
median of 172 months (8–769 months). Each patient
was followed-up in the Outpatient Clinic or at the office
of a practicing physician at 3, 6 and 12 months after
LTx, and also every 12 months for those patients who
had uneventful course.
Study design
After approval of the study by the local ethics committee,
a self-administered EORTC QLQ-C30-questionnaire with
an additional LTx questionnaire to assess the HRQoL was
sent to selected patients for cross-section analysis. Each
questionnaire sheet was sent with an informed consent
sheet; the latter was signed by the patient. The question-
naire contained 30 main questions related to various
diseases. The EORTC QLQ-C30-questionnaire has 5
function scales (physical functioning, role functioning,
cognitive functioning, emotional functioning, social func-
tioning) and 3 symptom scales (fatigue, pain, nausea,
vomiting). Moreover, the questionnaire included a Global
Health-scale, Quality of Life-scale and additional parame-
ters commonly used to assess typical clinical symptoms/
signs and status of cancer patients (dyspnea, loss of appe-
tite, sleep disturbance, constipation, diarrhea, financial dif-
ficulties) [12]. These scales were supplemented by social
demographic data, including age, sex, marital status,
school and professional education, number of children,
size of hometown, working status and working position
[12]. For easier interpretation, the assessed scores were
transformed to a scale ranging from 0 to 100. Thus, high
levels of global health, QOL and function scales indicated
a higher ability, whereas high scores of symptom-scales
indicated suffering of the patient [12].
The following eleven social demographic parameters
were entered in the correlation analysis: age at time of
LTx (16 to <47 years vs. ≥47 to <57 years vs. ≥57 years),
sex, marital status, presence of children, highest gradu-
ation, completed professional training, working status
(employed, unemployed), job position, size of home-
town, place of follow up after LTx and distance between
home and transplant center (≤155 km vs. >155 km). A
cutoff value of 155 km was chosen as it reflects the
distance to the next transplant center. Furthermore, the
following six allocation parameters were entered in the
correlation analysis: urgency for LTx (HU for high
urgent indication, T for patients with chronic disease),
duration of waiting before LTx (<180 days vs. ≥180 days),
era of organ allocation (ELAS- vs. MELD-era), presence
or absence of HCC, duration of hospitalization at trans-
plant center (<28 days vs. ≥28 days), and presence or
lack of malignant tumor after LTx. A cutoff of 180 days
waiting before LTx was chosen as patients transplanted
after less than 180 days were in most cases more instable
with a higher priority than patients who waited longer.
The cutoff of 28 days patient hospitalization was chosen
as most patients with a hospital stay longer than 28 days
after transplantation were hospitalized due to complica-
tions after surgery.
To quantify improvement in function- and symptom-
scores, we compared the scores and QOL-assessment
before LTx to those at follow-up. For meaningful com-
parison, the study cohort was divided into three groups;
the 0 to <53 group (representing those who underwent
LTx 0 to <53 months before assessment), the ≥53 to
<114 group (≥53 to <114 months) and the ≥114 group
(≥114 months). Cutoffs between the groups of age at
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time of LTx were chosen to reflect different stages of social
and working life. As a control group, we used the reference
data of the common German society, which were also eval-
uated by an EORTC QLQ-C30-questionnaire by Schwarz
and Hinz [13].
Statistical analysis
All metric parameters were expressed as total numbers
(%) or mean ± standard deviation. To test the influence
of social demographic and clinical parameters on Quality
of Life-Functioning and -Symptom Scores we performed
a simple and multiple linear regression analysis. Signifi-
cant variables in unviariate analysis were then included
in stepwise forward multiple linear regression to perform
multivariate testing. Positive values for stadardized re-
gression coefficient b lead to an increase, negative values
to a decrease in tested functioning and symptom score
items. Collinearity was not present with tolerance values
well above 0.2. A p value <0.05 was considered statisti-
cally significant. All analyses described in this paper
were conducted using the Statistical Package for Social
Sciences software (version 22.0, SPSS Inc., Chicago, IL).
Results
Study population
At the time of the QOL-assessment, the questionnaire
was sent to 238 patients. Of the 252 patients, 14 patients
had transferred and followed up at a different transplant
center and therefore their data were excluded from the
analysis. Of the remaining 238 patients, completed ques-
tionnaires were returned by 173 patients (73 %). The
reason for the no return of the questionnaire in the
remaining 65 patients was unwillingness to return in 39
(15.5 %) and 26 (10.3 %) had died or moved to foreign
countries after surgery. Among the 173 patients that
returned the questionnaire, 19 (7.5 %) were relisted for
LTx. The mean age of the patients at the time of LTx
was 52.7 ± 11.9 years. Most of the patients were ≥57 years
old (40 %), followed by the group ≥47 to <57 (33 %) and
the group <47 years (27 %) (Table 1). Of these patients
117 (49.2 %) underwent LTx during the ELAS-era and
121 (50.8 %) during the MELD-era. The mean waiting
time till LTx was 317.6 ± 484.8 days. During the ELAS-
era, the mean waiting time was 336 days and the mean
MELD-score was 15. In the MELD-era, the waiting time
was shorter (302 days) and MELD-score was higher (19
points). The mean duration of hospitalization was longer
for patients in the ELAS-era (36 days), compared with
that in the MELD-era (32 days). Only 18 (7.8 %) of the
patients required urgent transplantation. The back-
ground liver diseases were alcoholic cirrhosis 53 (31 %),
hepatitis C-cirrhosis in 22 (13 %), HCC in 21 (12 %),
cholestatic liver disease in 20 (12 %), cryptogenic cirrho-
sis in 10 (6 %), benign liver tumors and polycystic liver
diseases in 11 (6 %), acute hepatic failure in 9 (5 %), hepa-
titis B in 8 (5 %), autoimmune hepatitis in 8 (5 %), meta-
bolic liver disease in 9 (5 %), Budd-Chiari-syndrome in 1
(1 %) and non-gastrointestinal secondary liver tumors in 1
(1 %) patient.
Most patients were followed-up at the Outpatients
Clinic of our transplantation center, and only a small
number of patients (n = 23, 13 %) were followed up at
private clinics.
Social demographic characteristics
The study cohort comprised 99 males and 69 females
(Table 1), and the majority were married (69.5 %). Fur-
thermore, a large proportion lived at least with one other
person; and 74 % had children. Most patients lived in
villages or small towns. With regard to the level of high-
est education, the largest group had secondary modern
school, followed by a secondary school certificate,
university-entrance diploma and technical college quali-
fication, and only 2.4 % had no graduation. The largest
group completed traineeship, followed by technical col-
lege, advanced technical college or university degree
(Table 1), whereas 7 % did not state the professional
education. With regard to job position, the majority of
patients were retired, followed by current workers,
unemployed and confirmed unfit for work (Table 1).
Among the working patients, the largest proportion were
employees, followed by workers, officials, self-employed
and leading executives (Table 1).
HRQoL-characteristics
The mean score was 71.6 for physical functioning, 64 for
role functioning and 67.5 for emotional functioning. Fur-
thermore, the mean scores for cognitive functioning,
social functioning and global health status were 73.1,
67.9 and 65.4, respectively. The mean scores for the
symptom-score-assessment were 41.6 for fatigue, 9 for
nausea and vomiting, 32.6 for pain and 27.8 for dyspnea.
For insomnia, the mean score was 39.3, for appetite loss
14.1, for constipation 12.9, for diarrhea 17.6 and 34.5 for
financial difficulties. Comparison of our data with those
of Schwarz and Hinz (13), who measured HRQoL in
2001 people of common German society using the
EORTC QLQ-C30-questionnaire, showed clinically rele-
vant worse HRQoL-scores in our study for fatigue, pain,
dyspnea, insomnia, diarrhea and financial difficulties.
However, the HRQoL-scores for nausea/vomiting, appe-
tite loss, global health status and constipation were com-
parable to those reported in the above study.
Further analysis of the functioning scores showed
expected improvement in all functioning scores with
longer follow-up period (between LTx and the HRQoL-
assessment). The social functioning scale was signifi-
cantly different among the groups (p = 0.013) (Fig. 1).
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The symptom scores tended to improve at ≥114 months
after LTx, but the difference for any of the assessed
symptoms was not statistically significant.
Results of correlation of social-demographic parameters
after multivariate testing
Correlating the age of the patients at the time of LTx, we
measured less constipation in the <47 patients (p = 0.032)
and less financial difficulties for patients >57 years
(p = 0.003). The mean score for emotional function-
ing increased with aging. In contrast, financial difficulties
were more common among younger age patients than
older patients. With regard to gender differences in
HRQoL, larger proportion of women suffered fatigue and
insomnia than men. Furthermore, cognitive function-
ing tended to be better in women than men albeit
insignificantly.
We also assessed the role of family and social network
by examining the effects of marital status on HRQoL.
HRQoL-scores for divorced patients were significantly
worst in physical functioning (p = 0.004). Surprisingly, sin-
gle patients, widowed patients, patients living alone and
having children had no effect on HRQoL. Further analysis
showed significantly worse HRQoL-scores for patients with
a lower education and graduation. Patients with a job had
significantly better HRQoL-scores. Patients with no gradu-
ation had significantly worst HRQoL-scores for cognitive
functioning (p = 0.03) and constipation (p = 0.022). Patients
with secondary school certificate had significantly worst
functioning scores for global health status (p = 0007). Pa-
tients with technical college degree (insomnia: p = 0.002),
secondary modern school certificate (financial difficulties:
p = 0.032) and university-entrance diploma (insomnia:
p = 0.009) showed significantly better symptom scores
for insomnia and financial difficulties (Fig. 2). An un-
expected significant worse symptom score for diarrhea
was measured in patients with technical college de-
gree (p = 0.012). Patients with no education had sig-
nificantly worst symptom-scores for diarrhea (p = 0.047)
and financial difficulties (p = 0.042). Workers had worse
symptom-scores in nausea and vomiting (p = 0.005). Being
employed was correlated with better HRQoL-scores.




Males n = 99 (59 %)
Females n = 69 (41 %)
Age (years)
16 to <47 years n = 46 (27 %)
≥ 47 to <57 years n = 58 (33 %)
≥ 57 years n = 69 (40 %)
Marital status
Single n = 21 (13 %)
Married n = 115 (70 %)
Relationship n = 7 (4 %)
Divorced n = 16 (10 %)
Widowed n = 7 (4 %)
Children
Yes n = 123 (74 %)
No n = 43 (26 %)
Living alone
Yes n = 35 (26 %)
No n = 99 (74 %)
Size of hometown
Major city (population >100,000) n = 41 (25 %)
Town (population 50,000–100,000) n = 16 (10 %)
Small town (population 5000–50,000) n = 52 (32 %)
Village (population–5000) n = 54 (33 %)
Highest education
Secondary school certificate n = 67 (40 %)
Technical college qualification n = 17 (10 %)
No graduation n = 3 (2 %)
Secondary modern school certificate n = 58 (35 %)
University-entrance diploma n = 22 (13 %)
Completed professional training
Traineeship n = 97 (69 %)
Technical college n = 18 (13 %)
Advanced technical college n = 8 (6 %)
University n = 7 (5 %)
No education n = 10 (7 %)
Employment status
Working n = 26 (17 %)
Housewife/husband n = 9 (6 %)
Retired n = 105 (68 %)
Certified unfit for work n = 5 (3 %)
Unemployed n = 5 (3 %)
Other n = 5 (3 %)
Table 1 Assessed social demographic factors using the EORTC
QLQ-C30-questionnaire (Continued)
Job position
Worker n = 18 (18 %)
Employee n = 42 (42 %)
Official n = 12 (12 %)
Executive employee n = 89 (9 %)
Self-employed n = 12 (12 %)
Other n = 7 (7 %)
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Working patients had significantly better scores in phys-
ical functioning (p = <0.001), role functioning (p = 0.01),
global health status (p = 0.02), fatigue (p = 0.002), dyspnoe
(p = 0.008) and insomnia (p = 0.032) (Fig. 3). To test the
influence of a high distance, that patients had to travel for
their follow up examinations, we compared HRQoL-
scores for patients with long and short distance to
the transplant center. Living in a distance >155 km
was associated with significantly worst HRQoL-scores
for role functioning (p = 0.023), emotional functioning
Fig. 1 Correlation of functioning scores to time between LTx and HRQoL-assessment (*p < 0.05)
Fig. 2 Correlation of symptom scores to highest education (*p < 0.05)
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(p = 0.035), fatigue (p = 0.014) and dyspnoe (p = 0.046)
(Fig. 4). Follow-up at transplant center had worst
HRQoL-scores for emotional functioning (p = 0.012),
cognitive functioning (p = 0.009), fatigue (p = 0.022)
and insomnia (p = 0.038). Size of hometown had no
effect on HRQoL. All significant HRQoL-scores are
shown in Table 2.
Results of correlations of allocation-related parameters
after multivariate testing
Among patients who underwent LTx after more than 180-
day waiting period, the HRQoL-score was significantly
better for fatigue (p = 0.023). The HRQoL-scores for phys-
ical functioning (p = 0.003), role functioning (p = 0.05) and
emotional functioning (p = 0.007) were significantly worse
Fig. 3 Correlation of symptom scores to employment status (*p < 0.05)
Fig. 4 Correlation of functioning scores to distance to transplant center (*p < 0.05)
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in patients with a hospital stay of ≥28 days (Fig. 5). A sig-
nificantly higher score for physical functioning (p = 0.001)
was noted in patients transplanted before the MELD-
allocation era. HU-status at time of transplantation was
associated with a significantly higher symptom score for
financial difficulties. There was no significant difference in
HRQoL based on background liver disease. Furthermore,
there was no significant difference in the incidence of
malignant tumor after LTx. All significant HRQoL-scores
are shown in Table 3.
Discussion
The present study assessed the impact of social-demo-
graphic factors and changes in the allocation system on
HRQoL, since the influence of these factors remain
controversial.
Using available data on German society as reference,
we assessed relevant low HRQoL for patients who under-
went LTx. The results were comparable to those published
by other investigators [6, 8, 14, 15]. One surprising result
was the global health status of the study patients, which
was only slightly worse in LTx recipients. One possible
reason for this observation is the structure of the EORTC
Table 2 Significant symptom- and functioning-scores related to
social demographic parameters







● Physical Functioning 92 (±11,1) <0.001 <0.001
● Role Functioning 82 (±22.5) 0.001 0.01
● Global Health Status 77 (±24.1) 0.005 0.02
● Fatigue 23 (±20.1) <0.001 0.002
● Dyspnoe 11 (±20.9) 0.004 0.008
● Insomnia 23 (±31.5) 0.013 0.032
● Pain 20 (±28.1) 0.035 n.s.
Retired:
● Physical Functioning 66 (±23.4) 0.001 n.s.
● Role Functioning 59 (±32.6) 0.038 n.s.
● Dyspnoe 32 (±33.6) 0.003 n.s.
No graduation:
● Cognitive Functioning 46 (±25) 0.027 0.03
● Constipation 25 (±31.9) 0.024 0.022
● Financial Difficulties 75 (±16.7) 0.034 n.s.
Secondary school:
● Global Health Status 68 (±23.6) 0.013 0.007
● Insomnia 48 (±36.6) 0.031 n.s.
● Diarrhea 13 (±20.9) 0.04 n.s.
Secondary modern school:
● Cognitive Functioning 79 (±24.1) 0.033 n.s.
● Insomnia 32 (±35.6) 0.017 0.002
Technical college qualification:
● Insomnia 58 (±37.5) 0.045 n.s.
University-entrance diploma:
● Pain 21 (±30.5) 0.046 n.s.
● Insomnia 23 (±24.4) 0.021 0.009
No education:
● Diarrhea 20 (±35.8) <0.001 <0.001
● Financial Difficulties 63 (±33.1) 0.011 0.042
Traineeship:
● Dyspnoe 30 (±32.7) 0.038 n.s.
Technical college:
● Diarrhea 20 (±28.1) 0.034 0.012
● Financial Difficulties 31 (±37.5) 0.041 0.032
Age <47 year:
● Role Functioning 74 (±27.7) 0.01 n.s.
● Physical Functioning 81 (±18.5) 0.001 n.s.
● Constipation 7 (±15.5) 0.032 0.032
● Financial Difficulties 47 (±40.5) 0.007 n.s.
Table 2 Significant symptom- and functioning-scores related to
social demographic parameters (Continued)
Age ≥57 years:
● Physical Functioning 65 (±22.9) 0.003 n.s.
● Diarrhea 11 (±20.8) 0.018 n.s.
● Financial Difficulties 22 (±33.2) <0.001 0.003
Divorced:
● Physical Functioning 71 (±25.1) 0.039 0.04
Living alone:
● Pain 18 (±29.4) 0.029 n.s.
Married:
● Diarrhea 15 (±24.2) 0.05 n.s.
Distance to transplant center
>155 km:
● Role Functioning 58 (±33.7) 0.011 0.023
● Emotional Functioning 64 (±26.1) 0.031 0.035
● Fatigue 47 (±29.4) 0.017 0.014
● Dyspnoe 34 (±33.3) 0.01 0.046
Follow up at transplant center:
● Emotional Functioning 66 (±25.5) 0.01 0.012
● Cognitive Functioning 72 (±25.3) 0.006 0.009
● Fatigue 44 (±27.8) 0.005 0.022
● Insomnia 43 (±36.3) 0.028 0.038
Size of hometown
(population 50.000–100.000):
● Global Health Status 53 (±22) 0.034 n.s.
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QLQ-C30-questionnaire whereas the last two questions
serve as subjective assessment of potential happiness.
Happiness might be stronger among patients that survive
LTx compared to healthy people, who cannot express the
feelings of surviving severe disease in the same way as pa-
tients who undergo LTx. Thus, we speculate that healthy
people tend to rate these questions less positively.
We measured an improvement of HRQoL with longer
period between LTx and HRQoL-assessment. This find-
ing could be due to the fact that patients who are too
sick to fill out the questionnaire or those who have died
are not included in the assessment of the impact of this
factor. Nevertheless, our results are similar to those of
other groups who reported improvement in QOL at one
year after LTx [3, 6, 8–11, 14, 15]. The reported effect of
age on HRQoL is controversial. For example, Desai et al.
[15] reported significantly worse HRQoL for patients
aged ≥50 years at the time of LTx, while Saab et al. [8]
indicated that the effect was marginal and not significant
in their patients aged ≥60 years, and Aberg et al. [14]
concluded that old age did not affect HRQoL. Our ana-
lysis showed that young age (16-47 years) correlated sig-
nificantly with better constipation and a trend of more
financial difficulties, as this score was only significantly
worst in the univariate analysis. Correspondingly, old
patients (>57 years) had a significantly lower score for
financial difficulties. This finding might be related to the
better financial security or early retirement of older
recipients, better social integration and perhaps better
family background. The notion of better HRQoL associ-
ated with financial security, higher social status and social
Table 3 Significant symptom- and functioning-scores related to
allocation-related parameters






Duration of waiting before LTx
≥180 days:
● Emotional Functioning 72 (±21.6) 0.036 n.s.
● Fatigue 36 (±25.9) 0.009 0.023
● Nausea/Vomiting 5 (±14.7) 0.012 n.s.
● Apetite loss 10 (±23.6) 0.012 –
Hospital stay ≥28 days:
● Physical functioning: 67 (±23.3) 0.021 0.003
● Role functioning: 58 (±30.7) 0.022 0.05
● Emotional functioning: 63 (±26.3) 0.005 0.007
● Social Functioning: 61 (±34.2) 0.006 –
● Fatigue 46 (±7.32) 0.037 n.s.
● Dyspnoe 33 (±33.5) 0.026 n.s.
●Constipation 9 (±17.5) 0.036 n.s.
● Financial Difficulties 41 (±40.5) 0.025 n.s.
Presence of HCC:
● Physical Functioning 64 (±26.1) 0.02 n.s.
Organ allocation in ELAS-era:
● Physical Functioning 75 (±22.5) 0.022 0.001
HU-status:
● Financial Difficulties 61 (±41.7) 0.017 0.025
Fig. 5 Correlation of functioning scores to duration of hospitalization (*p < 0.05)
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background was confirmed by the finding of significantly
worse physical functioning in divorced patients, which
might reflect depression after LTx. Furthermore, better
HRQoL-scores were also noted in patients with higher
education, higher graduation and employed patients, with
associated higher income and probably high social status.
These results are similar to those of earlier studies, which
showed that employment or earlier return to employment
after LTx was associated with better HRQOL [14, 16, 17],
and conversely, that low monthly family income per capita
was associated with low HRQoL-scores [18]. Our finding
of the lack of relationship between gender and HRQoL is
similar to that of previous studies [8, 14], but different
from others [9, 15] who showed poor HRQoL-scores in
LTx women. Further studies are needed to establish the ef-
fect of gender on the HRQoL score.
Of special interest was the finding related to the effect
of distance from the transplant center. This became
especially important since 2007 after noticing a higher
number of concerned patients who lived far away from
the transplant center. These concerns are potentially re-
lated to the withdrawal of payments costs of travel from
home to the transplant center by the German health in-
surance in 2007. This point is peculiar to Germany and
is especially important where reduction of transplant
centers is currently being discussed by the German health
care system. Any such reduction would probably result in
further financial burden to the patients, with potential low
compliance and lesser visits to the medical care centers
for post LTx-follow up. This might worsen HRQoL for
such patients. In this study, higher distance to transplant
center correlated with significantly lower HRQoL. How-
ever, financial difficulties did not correlate with a higher
distance to the transplant center. Financial difficulties
were significantly higher in younger patients, divorced pa-
tients, low educated, unemployed patients or patients with
HU-status after transplantation. For HU-status patients
the sudden event of liver failure is a dramatic event, where
patients are pulled out of their every day life and working
position. Therefore, financial support should be provided
to this group of patients to compensate for higher travel
costs. The significantly worst HRQoL-scores for patients
followed up at the transplant center were surprising. An
explanation could be, that most patients followed up at
our transplant center are patients with complications after
transplantation. Another explanation could be a negatively
influence on HRQoL-scores in patients who filled out the
questionnaire after a longer journey to the transplant cen-
ter’s outpatient clinic.
The MELD-allocation system was established in the
Eurotransplant area in 2006. While the system reduced
waiting-list mortality, it also reduced the one-year survival
rate after LTx [19]. The reported correlation between
HRQoL and pre-transplant MELD-score varies widely
among the published studies, where authors indicated that
high pre-transplant MELD-scores correlate with higher
mortality rate after LTx [20], whereas others [11, 21] re-
port better physical functioning in patients with high
MELD-scores compared to those with low MELD-scores.
Saab et al. [22] concluded that pre-transplant MELD-
score did not influence post-LTx HRQoL. To our know-
ledge, there are no studies that compared the effects of
different allocation-systems on post-LTx HRQoL. Our re-
sults showed significant effect for the allocation-era on
post-LTx HRQoL. Physical functioning was significantly
better in patients who received LTx during the ELAS-era
than the MELD-era. In this context, patients with shorter
follow-up had overall worse HRQoL-scores compared
with longer follow-up period. On the other hand, patients
who underwent LTx during the ELAS-era had a lower
pre-transplant MELD-score than the MELD-era. Fur-
thermore, the waiting time was longer in patients
who received LTx during the ELAS-era. The fact that
patients with longer waiting time had significantly
better symptom-scores than those with shorter waiting
time suggests that patients who underwent LTx during the
ELAS-era were less sick than those during the MELD-era.
The duration of hospitalization was longer for patients
who underwent LTx during the ELAS-era. This finding is
probably related to the improvement in postoperative care
and medical system at our center after 1988. It should be
noted that a significant proportion of patients who re-
ceived LTx during the MELD-era were transferred after
hospital discharge to rehabilitation centers, which could
have distorted the data on duration of hospitalization dur-
ing the MELD-era. Nevertheless, patients with mean hos-
pital stay ≥28 days had significantly worse HRQoL for
most of the evaluated functioning-scores.
Our results showed no significant difference in HRQoL
between patients with and without HCC patients. The same
finding was noted in patients of the long-term follow-up
group who were diagnosed with malignancy after LTx. This
might be due to the differences in the number of patients
with and without HCC and the small number of patients
who developed malignancies after LTx. In this regard, there
is little or no information on HRQoL of HCC-patients after
LTx. One study by Mabrouk et al. [23] reported signifi-
cantly lower HRQoL in transplanted HCC-patients. Fur-
thermore, another study showed a significant effect on the
composite mental HRQoL score, but did not further specify
the neoplasms entity [11]. Aberg et al. [14] also showed no
significant difference in HRQoL between patients with and
without HCC in their study of 19 patients. The effect of
tumor-recurrence on HRQoL could not be evaluated in this
study since tumor-recurrence was noted in only 1 patient.
Further studies of larger population samples are needed to
investigate the effects of HCC, tumor recurrence and devel-
opment of malignancies on HRQoL.
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The present study has several limitations related
mainly to the study design. First, the data were assessed
by cross-sectional analysis, which is less informative than
those assessed by longitudinal study. Nevertheless, the
sample size was relatively large. Second, selection bias
cannot be ruled out; the HRQoL data did not include
those patients who were too ill to respond to the ques-
tionnaire. Third, some patients might have overesti-
mated or underestimated their activities or may have
misinterpreted the questions in the self-administered
questionnaire.
Conclusions
The HRQoL for fatigue, pain, dyspnea, insomnia and fi-
nancial difficulties was clinically worse in participants of
this study (patients who underwent LTx) compared to
the German public. Change of the allocation mode was
affected by worst physical functioning. HCC had no ef-
fect on HRQoL. However, the number of HCC patients
was relatively small and this point needs to be evaluated
in future studies with a larger number of HCC patients.
Less educated patients, divorced patients, a longer
distance to transplant center, shorter waiting time and
longer hospitalization were associated with lower HRQoL-
scores, probably reflecting a state of depression. Especially,
these patients should be supervised carefully and treated
with psychotherapeutic supervision. Working patients had
better HRQoL-scores in functioning and symptom-scores.
Furthermore, financial difficulties were an onerous par-
ameter for young patients, patients with HU-status or
less educated patients. These patients should be sup-
ported financially and rehabilitated in their employment
status in society.
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